Sep 9, 2021 Syros Announces First Patient Dosed in SELECT-AML-1 Trial of Tamibarotene in Combination with Venetoclax and Azacitidine in Newly Diagnosed Unfit AML
Aug 5, 2021 Syros Reports Second Quarter 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
Aug 5, 2021 Syros Announces Agreement with Roche to Evaluate SY-5609 as Part of a Novel Combination for Treatment of Colorectal Cancer
May 6, 2021 Syros Reports First Quarter 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
